scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PNAS..10720947K |
P356 | DOI | 10.1073/PNAS.1015671107 |
P8608 | Fatcat ID | release_s3n7thrfijfqzgsptv4rlk4tja |
P953 | full work available at URL | https://europepmc.org/articles/pmc3000257?pdf=render |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21078964/?tool=EBI | ||
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21078964/pdf/?tool=EBI | ||
https://europepmc.org/articles/PMC3000257 | ||
https://europepmc.org/articles/PMC3000257?pdf=render | ||
https://doi.org/10.1073/pnas.1015671107 | ||
https://pnas.org/doi/pdf/10.1073/pnas.1015671107 | ||
P932 | PMC publication ID | 3000257 |
P698 | PubMed publication ID | 21078964 |
P5875 | ResearchGate publication ID | 47794315 |
P50 | author | Solomon Halbert Snyder | Q1681665 |
Kent Werner | Q81303126 | ||
Michael A Koldobskiy | Q125338744 | ||
M Scott Vandiver | Q125339483 | ||
P2093 | author name string | Adele M. Snowman | |
Krishna R. Juluri | |||
Seyun Kim | |||
Anutosh Chakraborty | |||
Shira Heletz | |||
P2860 | cites work | Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases | Q22010845 |
Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage | Q59098609 | ||
Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 | ||
PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 | ||
ASPP proteins specifically stimulate the apoptotic function of p53 | Q24291844 | ||
A conserved family of enzymes that phosphorylate inositol hexakisphosphate | Q24301881 | ||
Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation | Q24338320 | ||
PUMA mediates the apoptotic response to p53 in colorectal cancer cells | Q24550772 | ||
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | Q24672792 | ||
Back in the water: the return of the inositol phosphates | Q28186774 | ||
Cell cycle regulation and p53 activation by protein phosphatase 2C alpha | Q28201863 | ||
p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa | Q28204059 | ||
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways | Q28213279 | ||
p21 is necessary for the p53-mediated G1 arrest in human cancer cells | Q28291118 | ||
Integral role of Noxa in p53-mediated apoptotic response | Q28510421 | ||
Blinded by the Light: The Growing Complexity of p53 | Q29547590 | ||
Requirement for p53 and p21 to sustain G2 arrest after DNA damage | Q29547667 | ||
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
Modes of p53 regulation | Q29615657 | ||
p53 is required for radiation-induced apoptosis in mouse thymocytes | Q29620281 | ||
Role of BAX in the apoptotic response to anticancer agents | Q31523620 | ||
Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases | Q33836143 | ||
Disruption of p53 in human cancer cells alters the responses to therapeutic agents | Q33853609 | ||
Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death | Q34366232 | ||
Inositol pyrophosphates regulate endocytic trafficking | Q34392736 | ||
Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma | Q35208535 | ||
p53 in recombination and repair | Q36423948 | ||
HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. | Q36446083 | ||
Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis | Q36497226 | ||
The p53 family in nervous system development and disease | Q36521923 | ||
Understanding the biological significance of diphosphoinositol polyphosphates ('inositol pyrophosphates'). | Q36711307 | ||
Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells | Q40046011 | ||
The multiple battles fought by anti-apoptotic p21. | Q40168692 | ||
Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. | Q40474530 | ||
Inositol diphosphate signaling regulates telomere length | Q42641267 | ||
Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates | Q42971039 | ||
Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions | Q44587829 | ||
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease | Q45297400 | ||
P433 | issue | 49 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | apoptotic process | Q14599311 |
P304 | page(s) | 20947-20951 | |
P577 | publication date | 2010-11-15 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | p53-mediated apoptosis requires inositol hexakisphosphate kinase-2 | |
P478 | volume | 107 |
Q35599795 | A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase |
Q39905040 | A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. |
Q34573044 | Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2. |
Q38841684 | Chemical pyrophosphorylation of functionally diverse peptides. |
Q38837404 | Chemical tools for interrogating inositol pyrophosphate structure and function. |
Q37020337 | Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice |
Q54349708 | Discovery of InsP6-kinases as InsP6-dephosphorylating enzymes provides a new mechanism of cytosolic InsP6 degradation driven by the cellular ATP/ADP ratio. |
Q41499357 | Establishing the stability and reversibility of protein pyrophosphorylation with synthetic peptides |
Q34263565 | Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles |
Q28540195 | Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon response |
Q63379297 | Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis |
Q64947264 | Inositol Hexakisphosphate Kinase-2 in Cerebellar Granule Cells Regulates Purkinje Cells and Motor Coordination via Protein 4.1N. |
Q41846418 | Inositol Hexakisphosphate Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar Purkinje Cells via Spectrin/Adducin. |
Q36176216 | Inositol Pyrophosphate Profiling of Two HCT116 Cell Lines Uncovers Variation in InsP8 Levels. |
Q59604012 | Inositol Pyrophosphates: Energetic, Omnipresent and Versatile Signalling Molecules |
Q52664251 | Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cells. |
Q38437282 | Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis |
Q44273064 | Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways |
Q33939404 | Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death |
Q34533714 | Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. |
Q36403568 | Inositol polyphosphate multikinase signaling in the regulation of metabolism |
Q36886772 | Inositol pyrophosphates as mammalian cell signals |
Q33570316 | Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2 |
Q35090038 | Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1 |
Q41512865 | Inositol pyrophosphates regulate cell growth and the environmental stress response by activating the HDAC Rpd3L. |
Q38110945 | Inositol pyrophosphates: between signalling and metabolism |
Q27010207 | Interferons as inducers of apoptosis in malignant cells |
Q37652730 | Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer |
Q44876576 | KO of 5-InsP7 kinase activity transforms the HCT116 colon cancer cell line into a hypermetabolic, growth-inhibited phenotype. |
Q92391632 | Knockdown of spliceosome U2AF1 significantly inhibits the development of human erythroid cells |
Q90203009 | Mechanisms of IFNalpha-1a-Induced Apoptosis in a Laryngeal Cancer Cell Line |
Q35065098 | Mind molecules |
Q93081839 | Nuclear Phosphoinositides: Their Regulation and Roles in Nuclear Functions |
Q34305020 | Obesity and cancer risk: evidence, mechanisms, and recommendations |
Q45903193 | PPIP5K1 Suppresses Etoposide-triggered Apoptosis. |
Q91458078 | Role of phosphate sensing in bone and mineral metabolism |
Q34396776 | Serine racemase regulated by binding to stargazin and PSD-95: potential N-methyl-D-aspartate-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA-AMPA) glutamate neurotransmission cross-talk. |
Q90597925 | Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases |
Q26786441 | The emerging roles of inositol pyrophosphates in eukaryotic cell physiology |
Q26851038 | The enzymes of human diphosphoinositol polyphosphate metabolism |
Q47250401 | The inositol pyrophosphate pathway in health and diseases |
Q36853305 | The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate/protein kinase Cδ cascade |
Q38816694 | hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer |